← FDA Drug Approvals (Drugs@FDA)

GAVRETO

NDA · New Drug Application · Sponsor: BLUEPRINT MEDICINES · Approved 2020-12-01

Drug application

FDA Application #

NDA214701

Application type

New Drug Application

Brand name

GAVRETO

Generic name

Pralsetinib

Active ingredients

PRALSETINIB

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

BLUEPRINT MEDICINES

First approval

2020-12-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown